Home4516 • TYO
add
Nippon Shinyaku Co Ltd
Nakaraang pagsara
¥5,295.00
Sakop ng araw
¥5,225.00 - ¥5,318.00
Sakop ng taon
¥2,967.00 - ¥6,529.00
Market cap
373.11B JPY
Average na Volume
340.86K
P/E ratio
11.98
Dividend yield
2.33%
Primary exchange
TYO
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (JPY) | Dis 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 47.49B | 13.10% |
Gastos sa pagpapatakbo | 18.06B | 36.52% |
Net na kita | 10.08B | -17.20% |
Net profit margin | 21.23 | -26.82% |
Kita sa bawat share | — | — |
EBITDA | 14.41B | -12.27% |
Aktuwal na % ng binabayarang buwis | 23.57% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (JPY) | Dis 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 60.77B | 9.65% |
Kabuuang asset | 328.11B | 15.34% |
Kabuuang sagutin | 43.91B | 19.73% |
Kabuuang equity | 284.20B | — |
Natitirang share | 67.40M | — |
Presyo para makapag-book | 1.26 | — |
Return on assets | 10.20% | — |
Return on capital | 11.61% | — |
Cash Flow
Net change in cash
| (JPY) | Dis 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 10.08B | -17.20% |
Cash mula sa mga operasyon | -1.94B | -219.60% |
Cash mula sa pag-invest | 775.00M | -59.78% |
Cash mula sa financing | -4.35B | -2.21% |
Net change in cash | -4.52B | -367.91% |
Malayang cash flow | -2.12B | -141.86% |
Tungkol
Nippon Shinyaku Co., Ltd. is a Japanese pharmaceutical company headquartered in Kyoto that develops, manufactures, and markets prescription drugs and functional foods. Founded in 1911, the company initially focused on herbal medicines before expanding into modern pharmaceuticals, with current therapeutic areas including urology, hematology, intractable and rare diseases, and gynecology. Nippon Shinyaku is listed on the Tokyo Stock Exchange and has developed treatments such as viltolarsen for Duchenne muscular dystrophy. Wikipedia
Itinatag
Okt 1, 1919
Website
Mga Empleyado
2,243
